The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $66.93

Today's change-2.16 -3.13%
Updated March 30 4:00 PM EDT. Delayed by at least 15 minutes.
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $66.93

Today's change-2.16 -3.13%
Updated March 30 4:00 PM EDT. Delayed by at least 15 minutes.

Perrigo Company PLC down (U.S.)$2.16

Perrigo Company PLC closed sharply lower Thursday, dropping (U.S.)$2.16 or 3.13% to (U.S.)$66.93. Over the last five days, shares have lost 1.80% and are down 19.58% for the last year to date. This security has underperformed the S&P 500 by 63.10% during the last year.

Key company metrics

  • Open(U.S.) $68.88
  • Previous close(U.S.) $69.09
  • High(U.S.) $68.93
  • Low(U.S.) $66.78
  • Bid / Ask(U.S.) $66.75 / (U.S.) $66.93
  • YTD % change-19.58%
  • Volume1,647,255
  • Average volume (10-day)1,557,050
  • Average volume (1-month)2,274,338
  • Average volume (3-month)1,843,653
  • 52-week range(U.S.) $66.78 to (U.S.) $133.53
  • Beta0.69
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward9.72×
  • Forward PEG5.78×
  • Indicated annual dividend(U.S.) $0.64
  • Dividend yield0.96%
  • Trailing EPS(U.S.) -$10.47
Updated March 30 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-26.62%

Perrigo Company PLC has a net profit margin of -26.62%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.50%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016Dec 31, 201512/31/2015
Revenue1,3551,4811,3832,770
Total other revenue--------
Total revenue1,3551,4811,3832,770
Gross profit5065675231,108
Total cost of revenue8499148601,661
Total operating expense2,8711,2431,6872,676
Selling / general / administrative285296309683
Research & development50474588
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1,687-14473243
Other operating expenses, total--------
Operating income-1,516238-30494
Interest income (expense), net non-operating-------89
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,572152-359-23
Income after tax-1,255194-3356
Income tax, total-316-43-25-29
Net income-1,255194-3356
Total adjustments to net income0------
Net income before extra. items-1,255194-3356
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1,255194-3356
Inc. avail. to common incl. extra. items-1,255194-3356
Diluted net income-1,255194-3356
Dilution adjustment00--0
Diluted weighted average shares143144143146
Diluted EPS excluding extraordinary itemsvalue per share-8.761.35-2.340.04
Dividends per sharevalue per share0.150.150.150.13
Diluted normalized EPSvalue per share-1.111.29-0.191.12